Literature DB >> 27445343

A return to ad libitum feeding following caloric restriction promotes hepatic steatosis in hyperphagic OLETF rats.

Melissa A Linden1, Justin A Fletcher1, Grace M Meers2, John P Thyfault3, M Harold Laughlin4, R Scott Rector5.   

Abstract

Hyperphagic Otsuka Long-Evans Tokushima fatty (OLETF) rats develop obesity, insulin resistance, and nonalcoholic fatty liver disease (NAFLD), but lifestyle modifications, such as caloric restriction (CR), can prevent these conditions. We sought to determine if prior CR had protective effects on metabolic health and NAFLD development following a 4-wk return to ad libitum (AL) feeding. Four-week-old male OLETF rats (n = 8-10/group) were fed AL for 16 wk (O-AL), CR for 16 wk (O-CR; ∼70% kcal of O-AL), or CR for 12 wk followed by 4 wk of AL feeding (O-AL4wk). CR-induced benefit in prevention of NAFLD, including reduced hepatic steatosis, inflammation, and markers of Kupffer cell activation/number, was largely lost in AL4wk rats. These findings occurred in conjunction with a partial loss of CR-induced beneficial effects on obesity and serum triglycerides in O-AL4wk rats, but in the absence of changes in serum glucose or insulin. CR-induced increases in hepatic mitochondrial respiration remained significantly elevated (P < 0.01) in O-AL4wk compared with O-AL rats, while mitochondrial [1-(14)C]palmitate oxidation, citrate synthase activity, and β-hydroxyacyl-CoA dehydrogenase activity did not differ among OLETF groups. NAFLD development in O-AL4wk rats was accompanied by increases in the protein content of the de novo lipogenesis markers fatty acid synthase and stearoyl-CoA desaturase-1 and decreases in phosphorylated acetyl-CoA carboxylase (pACC)/ACC compared with O-CR rats (P < 0.05 for each). The beneficial effects of chronic CR on NAFLD development were largely lost with 4 wk of AL feeding in the hyperphagic OLETF rat, highlighting the importance of maintaining energy balance in the prevention of NAFLD.

Entities:  

Keywords:  caloric restriction; de novo lipogenesis; hepatic steatosis; mitochondria

Mesh:

Substances:

Year:  2016        PMID: 27445343      PMCID: PMC5076013          DOI: 10.1152/ajpgi.00089.2016

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  38 in total

Review 1.  Nonalcoholic fatty liver disease: an agenda for clinical research.

Authors:  Zobair M Younossi; Anna Mae Diehl; Janus P Ong
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

2.  Up-regulation of stearoyl-CoA desaturase 1 and elongase 6 genes expression in rat lipogenic tissues by chronic food restriction and chronic food restriction/refeeding.

Authors:  Jacek Turyn; Magdalena Stojek; Julian Swierczynski
Journal:  Mol Cell Biochem       Date:  2010-08-19       Impact factor: 3.396

Review 3.  Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

Authors:  Christian Thoma; Christopher P Day; Michael I Trenell
Journal:  J Hepatol       Date:  2011-07-01       Impact factor: 25.083

4.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

5.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

6.  Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model.

Authors:  R Scott Rector; Grace M Uptergrove; E Matthew Morris; Sarah J Borengasser; M Harold Laughlin; Frank W Booth; John P Thyfault; Jamal A Ibdah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

7.  Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease.

Authors:  Maria Cristina Elias; Edison Roberto Parise; Luciana de Carvalho; Denis Szejnfeld; João Prola Netto
Journal:  Nutrition       Date:  2009-12-22       Impact factor: 4.008

8.  Changes in skeletal muscle mitochondria in response to the development of type 2 diabetes or prevention by daily wheel running in hyperphagic OLETF rats.

Authors:  R Scott Rector; Grace M Uptergrove; Sarah J Borengasser; Catherine R Mikus; E Matthew Morris; Scott P Naples; Matthew J Laye; M Harold Laughlin; Frank W Booth; Jamal A Ibdah; John P Thyfault
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-03-16       Impact factor: 4.310

9.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

Authors:  Robert J Wong; Maria Aguilar; Ramsey Cheung; Ryan B Perumpail; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2014-11-25       Impact factor: 22.682

10.  Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

Authors:  Jason M Hui; James G Kench; Shivakumar Chitturi; Archana Sud; Geoffrey C Farrell; Karen Byth; Pauline Hall; Mahbub Khan; Jacob George
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

View more
  5 in total

Review 1.  Exercise Combats Hepatic Steatosis: Potential Mechanisms and Clinical Implications.

Authors:  John P Thyfault; R Scott Rector
Journal:  Diabetes       Date:  2020-04       Impact factor: 9.461

2.  A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice.

Authors:  Mary P Moore; Rory P Cunningham; Rachel A H Davis; Sarah E Deemer; Brandon M Roberts; Eric P Plaisance; R Scott Rector
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-01-27       Impact factor: 4.052

3.  Partial Body Mass Recovery After Caloric Restriction Abolishes Improved Glucose Tolerance in Obese, Insulin Resistant Rats.

Authors:  Manuel A Cornejo; Julie Nguyen; Joshua Cazares; Benny Escobedo; Akira Nishiyama; Daisuke Nakano; Rudy M Ortiz
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-10       Impact factor: 5.555

4.  The Protective Effect of Cynara Cardunculus Extract in Diet-Induced NAFLD: Involvement of OCTN1 and OCTN2 Transporter Subfamily.

Authors:  Francesca Oppedisano; Carolina Muscoli; Vincenzo Musolino; Cristina Carresi; Roberta Macrì; Caterina Giancotta; Francesca Bosco; Jessica Maiuolo; Federica Scarano; Sara Paone; Saverio Nucera; Maria Caterina Zito; Miriam Scicchitano; Stefano Ruga; Monica Ragusa; Ernesto Palma; Annamaria Tavernese; Rocco Mollace; Ezio Bombardelli; Vincenzo Mollace
Journal:  Nutrients       Date:  2020-05-15       Impact factor: 5.717

5.  Hepatic ballooning degeneration: a new feature of the refeeding syndrome in rats.

Authors:  Alceu Afonso Jordao; Amanda Canale; Mariângela Brunaldi; Sergio Zucoloto
Journal:  Clin Exp Hepatol       Date:  2020-12-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.